We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$120B
AUM Growth
+$5B
(+4.4%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
335
New
4
Increased
58
Reduced
216
Closed
7
Avg Time Held
6
years
Top 10 Avg Time Held
5.4
years
Top 20 Avg Time Held
5.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$227M |
| 2 |
GSK
GSK
|
+$68.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$48.2M |
| 4 |
Intel
INTC
|
+$45M |
| 5 |
Capri Holdings
CPRI
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$764M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$262M |
| 4 |
Caterpillar
CAT
|
+$148M |
| 5 |
Novartis
NVS
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.41% |
| 2 | Technology | 30.05% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
JELD-WEN Holding
JELD
$118M
| $6.34M | 0.01% |
361,600
| – | – |
2021 Q1
9 quarters
|
|
277
Constellation Brands
STZ
$21.9B
| $6.33M | 0.01% |
25,700
| – | – |
2017 Q2
24 quarters
|
|
278
GitLab
GTLB
$9.32B
| $6.24M | 0.01% |
122,140
-7,550
| -6% | -$281K |
2021 Q4
6 quarters
|
|
279
Standard BioTools
LAB
$258M
| $6.22M | 0.01% |
3,220,917
-1,276,656
| -28% | -$2.52M |
2013 Q2
40 quarters
|
|
280
Boot Barn
BOOT
$3.65B
| $5.68M | ﹤0.01% |
67,100
| – | – |
2015 Q1
33 quarters
|
|
281
Rivian
RIVN
$18.9B
| $5.65M | ﹤0.01% |
339,200
-4,300
| -1% | -$60.1K |
2021 Q4
6 quarters
|
|
282
Allegiant Air
ALGT
$1.92B
| $5.56M | ﹤0.01% |
44,050
| – | – |
2013 Q2
40 quarters
|
|
283
Fortinet
FTNT
$133B
| $5.33M | ﹤0.01% |
70,450
+1,445
| +2% | +$98.3K |
2023 Q1
1 quarter
|
|
284
DELISTED
Immunogen Inc
IMGN
| $5.15M | ﹤0.01% |
273,100
-10,000
| -4% | -$118K |
2013 Q2
40 quarters
|
|
285
Tenable Holdings
TENB
$4.33B
| $4.73M | ﹤0.01% |
108,650
-3,950
| -4% | -$161K |
2022 Q1
5 quarters
|
|
286
Nektar Therapeutics
NKTR
$1.29B
| $4.69M | ﹤0.01% |
543,325
-222,210
| -29% | -$2.37M |
2013 Q2
40 quarters
|
|
287
Haleon
HLN
$43.7B
| $4.62M | ﹤0.01% |
551,400
| – | – |
2022 Q3
3 quarters
|
|
288
Ciena
CIEN
$50.6B
| $4.44M | ﹤0.01% |
104,485
+2,000
| +2% | +$91.1K |
2020 Q2
12 quarters
|
|
289
Guardant Health
GH
$22.3B
| $4.4M | ﹤0.01% |
122,976
-58,068
| -32% | -$1.67M |
2020 Q3
11 quarters
|
|
290
Shutterstock
SSTK
$170M
| $4.04M | ﹤0.01% |
+82,970
| New | +$4.73M |
2023 Q2
0 quarters
|
|
291
GrowGeneration
GRWG
$87.8M
| $3.94M | ﹤0.01% |
1,159,900
| – | – |
2022 Q1
5 quarters
|
|
292
OraSure Technologies
OSUR
$263M
| $3.88M | ﹤0.01% |
773,720
-22,500
| -3% | -$135K |
2013 Q2
40 quarters
|
|
293
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.78M | ﹤0.01% |
220,300
-14,300
| -6% | -$234K |
2013 Q2
40 quarters
|
|
294
Gildan
GIL
$7.78B
| $3.21M | ﹤0.01% |
99,430
| – | – |
2014 Q2
36 quarters
|
|
295
DELISTED
Sage Therapeutics
SAGE
| $2.99M | ﹤0.01% |
63,600
-2,800
| -4% | -$139K |
2021 Q4
6 quarters
|
|
|
NUVA
296
DELISTED
NuVasive, Inc.
NUVA
| $2.91M | ﹤0.01% |
69,900
-3,300
| -5% | -$135K |
2013 Q2
40 quarters
|
|
297
Ingevity
NGVT
$2.43B
| $2.85M | ﹤0.01% |
49,000
| – | – |
2017 Q4
22 quarters
|
|
298
Ambarella
AMBA
$2.8B
| $2.77M | ﹤0.01% |
33,100
-57,500
| -63% | -$4.21M |
2020 Q3
11 quarters
|
|
299
Deckers Outdoor
DECK
$11.8B
| $2.43M | ﹤0.01% |
27,684
+1,200
| +5% | +$96.5K |
2022 Q4
2 quarters
|
|
300
Cboe Global Markets
CBOE
$32.2B
| $2.33M | ﹤0.01% |
16,900
-3,100
| -16% | -$423K |
2018 Q3
19 quarters
|
|
Similar funds
Primecap Management's Q2 2023 Portfolio in Review
As of Q2 2023, Primecap Management held 335 positions worth $120B, up 4.4% from $115B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management withdrew a net $4.23B in Q2 2023, closing 7 positions and reducing 216 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Sphere Entertainment worth $17.1M.
- Primecap Management's largest Q2 2023 buy was Sphere Entertainment: 623,078 shares worth $17.1M.
- Primecap Management added most to Seagen Inc. Common Stock in Q2 2023, an estimated $227M increase.
- Primecap Management's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $764M.
- Primecap Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $27M.
- Primecap Management's ten largest holdings make up 34% of its $120B portfolio in Q2 2023.
- Primecap Management opened 4 new positions and closed 7 in Q2 2023.
- Primecap Management's portfolio value rose 4.4% quarter-over-quarter to $120B.
Based on Primecap Management's 13F filing for Q2 2023, filed 11 Aug 2023.